SOD1 and amyotrophic lateral sclerosis: Guanabenz-treated male G93A-SOD1 mice exhibited accelerated age of onset of paresis and age at ALS-related death by 10 and 4.5 days respectively (p values = 0.02 and 0.02) (Fig 4A and 4B, Table 2, Table 3).